infecti
diseas
major
contributor
morbid
mortal
among
infant
children
young
anim
ideal
strategi
practic
earli
age
confer
protect
infecti
diseaserel
morbid
mortal
experienc
later
life
vaccin
commonli
use
diseas
intervent
strategi
howev
mani
issu
complic
vaccin
neonat
includ
vaccin
safeti
vaccin
efficaci
vaccin
regimen
may
unsuccess
stimul
protect
immun
neonat
due
ontogen
immun
immatur
passiv
acquir
matern
deriv
immun
mdi
interf
activ
immun
develop
mdi
critic
contributor
neonat
immun
respons
mdi
passiv
transfer
neonat
across
placenta
via
colostrum
milk
human
mice
via
colostrum
milk
pig
hors
cattl
mdi
directli
respons
prevent
reduc
impact
infecti
diseas
neonat
piglet
mdi
shown
least
partial
protect
mani
agent
includ
escherichia
coli
mycoplasma
hyopneumonia
hyopneumonia
transmiss
gastroenter
viru
tge
porcin
circoviru
type
howev
mdi
may
interfer
adapt
immun
respons
follow
vaccin
ie
passiv
interfer
exampl
young
pig
vaccin
face
antigenspecif
mdi
suppress
antibodi
respons
hyopneumonia
bordetella
bronchiseptica
pseudorabi
swine
influenza
viru
siv
classic
swine
fever
csf
cellmedi
immun
cmi
antibodymedi
immun
ami
mediat
transfer
neonat
via
colostrum
amount
transfer
matern
antibodi
often
correl
level
inhibit
neonat
ami
respons
effect
matern
deriv
cmi
neonat
immun
respons
develop
less
well
understood
whether
neonat
cmi
respons
follow
vaccin
challeng
inhibit
face
mdi
unclear
matern
cmi
transfer
neonat
across
placenta
colostrum
clearli
particip
neonat
cmi
respons
transfer
function
tuberculinspecif
immun
cell
evidenc
delayedtyp
hypersensit
dth
demonstr
infant
vaccin
mother
transfer
cmi
sensit
trichinella
spirali
coccidioid
immiti
antigen
evidenc
antigenspecif
prolifer
nematod
load
dth
respect
demonstr
neonat
mice
born
vaccin
dam
lymphocyt
isol
calv
receiv
colostr
cell
bovin
viral
diarrheal
viru
bvdv
vaccin
mother
demonstr
greater
cmi
respons
bvdv
compar
lymphocyt
isol
calv
receiv
acellular
colostrum
shown
matern
colostr
cell
hyopneumonia
vaccin
dam
transfer
piglet
particip
vivo
neonat
cmi
respons
hyopneumonia
upon
antigen
challeng
still
unclear
whether
matern
deriv
cmi
particip
immun
interfer
otherwis
affect
activ
cmi
respons
develop
piglet
word
whether
piglet
vaccin
face
mdi
develop
antigenspecif
cmi
respons
remain
elucid
cmi
critic
immun
respons
hyopneumonia
matern
hyopneumoniaespecif
cell
particip
immun
respons
follow
hyopneumonia
antigen
challeng
piglet
studi
conduct
test
hypothesi
piglet
respond
hyopneumonia
vaccin
cmi
ami
respons
vaccin
face
hyopneumoniaespecif
mdi
field
set
piglet
hyopneumoniaespecif
mdi
fail
show
vaccin
induc
ami
respons
contrast
piglet
hyopneumoniaespecif
mdi
vaccin
hyopneumonia
develop
primari
secondari
hyopneumoniaespecif
cmi
respons
prior
experiment
vaccin
sow
hyopneumoniaespecif
antibodi
figur
expect
due
prior
onfarm
vaccin
hyopneumonia
experiment
vaccin
sow
increas
hyopneumoniaespecif
ami
respons
blood
colostrum
figur
hyopneumoniaespecif
lymphoprolif
respons
colostrum
figur
sow
vaccin
studi
significantli
higher
hyopneumoniaespecif
serum
antibodi
sampl
posit
p
ratio
compar
vaccin
p
compar
sow
vaccin
part
studi
p
figur
similarli
experiment
vaccin
sow
significantli
greater
hyopneumoniaespecif
antibodi
p
ratio
colostrum
compar
nonvaccin
sow
figur
colostr
mononuclear
cell
cmc
experiment
vaccin
sow
demonstr
significantli
greater
hyopneumoniaespecif
prolifer
compar
cmc
nonvaccin
sow
p
figur
newborn
piglet
hyopneumonia
swine
placenta
prohibit
transfer
immun
compon
utero
evid
transplacent
infect
hyopneumonia
prior
colostrum
ingest
piglet
demonstr
hyopneumoniaespecif
immun
either
ami
figur
cmi
figur
follow
colostrum
ingest
piglet
vaccin
sow
significantli
greater
hyopneumonia
antibodi
p
ratio
compar
piglet
nonvaccin
sow
p
figur
blood
mononuclear
cell
bmc
isol
piglet
vaccin
sow
hr
suckl
prolifer
significantli
respons
stimul
hyopneumonia
antigen
compar
bmc
isol
piglet
nonvaccin
sow
p
figur
differ
hyopneumoniaespecif
antibodi
p
ratio
lymphoprolifer
rel
piglet
treatment
group
prior
piglet
vaccin
data
shown
hyopneumonia
vaccin
administ
piglet
age
piglet
vaccin
age
attempt
stimul
endogen
immun
presenc
transfer
antigen
specif
mdi
hyopneumoniaespecif
antibodi
level
differ
among
piglet
nonvaccin
sow
rel
piglet
vaccin
statu
day
post
vaccin
dpv
figur
dpv
figur
two
piglet
consid
hyopneumoniaeantibodi
neg
base
p
ratio
respond
vaccin
ami
respons
dpv
though
magnitud
respons
great
enough
result
differ
piglet
group
hyopneumoniaespecif
antibodi
p
ratio
among
piglet
nonvaccin
sow
appear
lower
dpv
dpv
compar
hr
suckl
differ
signific
decreas
dpv
dpv
hyopneumoniaespecif
antibodi
p
ratio
among
piglet
vaccin
sow
differ
dpv
rel
piglet
vaccin
statu
figur
chang
mean
hyopneumoniaespecif
antibodi
p
ratio
among
nonvaccin
piglet
vaccin
sow
vs
np
dpv
dpv
howev
vaccin
piglet
vaccin
sow
vs
vp
lower
hyopneumoniaespecif
antibodi
p
ratio
dpv
compar
dpv
p
vs
np
piglet
greater
hyopneumonia
antibodi
p
ratio
compar
vs
vp
piglet
dpv
figur
assess
piglet
hyopneumoniaespecif
cmi
ex
vivo
hyopneumoniaespecif
prolifer
assess
prolif
respons
concanavalin
cona
detect
bmc
across
piglet
dpv
dpv
data
shown
vaccin
presenc
mdi
vs
vp
piglet
result
earlier
hyopneumoniaespecif
prolif
respons
dpv
compar
group
piglet
figur
interestingli
bmc
isol
vaccin
piglet
prolifer
significantli
respons
stimul
hyopneumonia
compar
bmc
isol
nonvaccin
piglet
regardless
sow
vaccin
statu
dpv
p
figur
differ
prolifer
bmc
isol
ns
vp
compar
vs
vp
piglet
dpv
bmc
isol
dpv
vs
vp
piglet
prolifer
respons
stimul
hyopneumonia
bmc
isol
group
piglet
dpv
similarli
hyopneumoniaespecif
prolif
respons
ns
vp
piglet
dpv
significantli
greater
group
piglet
dpv
assess
piglet
hyopneumoniaespecif
cmi
vivo
dth
test
perform
control
dth
test
piglet
across
treatment
group
respond
phytohemagglutinin
pha
none
respond
salin
inject
time
dpv
dpv
data
shown
hyopneumoniaespecif
dth
lesion
detect
piglet
across
treatment
group
time
point
figur
vs
vp
piglet
significantli
larger
hyopneumoniaespecif
dth
lesion
mean
orthogon
diamet
compar
treatment
group
dpv
p
figur
hyopneumoniaespecif
dth
lesion
among
nonvaccin
piglet
differ
orthogon
diamet
dpv
figur
mean
orthogon
diamet
hyopneumoniaespecif
lesion
nonvaccin
piglet
smaller
ns
vp
piglet
p
vs
vp
piglet
p
figur
dpv
contrast
prolif
respons
hyopneumoniaespecif
dth
lesion
vs
vp
piglet
significantli
larger
ns
vp
piglet
p
dpv
mean
orthogon
diamet
hyopneumoniaespecif
dth
lesion
significantli
larger
dpv
compar
dpv
ns
vp
piglet
matern
deriv
antibodi
lymphocyt
acquir
across
placenta
postnat
colostrum
milk
critic
particip
neonat
immun
respons
neonat
vaccin
practic
across
varieti
antigen
effort
confer
protect
specif
pathogen
period
neonat
immun
system
matur
matern
antibodi
wane
howev
mdi
may
interfer
immun
prime
gener
memori
respons
follow
neonat
vaccin
studi
conduct
determin
whether
neonat
piglet
respond
ami
andor
cmi
respons
hyopneumonia
vaccin
vaccin
face
matern
hyopneumoniaespecif
immun
determin
whether
cmi
ami
respons
could
induc
piglet
mdi
piglet
hyopneumonia
vaccin
nonvaccin
dam
vaccin
hyopneumonia
age
piglet
hyopneumoniaespecif
antibodi
lymphoprolif
dth
respons
measur
dpv
dpv
vaccin
piglet
vaccin
sow
induc
ami
respons
piglet
rise
hyopneumonia
p
ratio
follow
piglet
vaccin
contrast
evid
antigenspecif
prolifer
dth
test
demonstr
hyopneumoniaespecif
cmi
prime
anamnest
respons
induc
follow
vaccin
piglet
hyopneumoniaespecif
mdi
taken
togeth
neonat
piglet
hyopneumoniaespecif
cmi
respons
induc
vaccin
least
wholli
inhibit
passiv
interfer
hyopneumoniaespecif
mdi
present
studi
evid
piglet
vaccin
face
mdi
develop
activ
hyopneumoniaespecif
ami
respons
within
dpv
result
agreement
hodgin
et
al
show
rise
serum
hyopneumonia
antibodi
titer
week
post
vaccin
piglet
vaccin
age
presenc
high
level
antigenspecif
mdi
lack
rise
hyopneumonia
antibodi
p
ratio
piglet
vaccin
face
mdi
like
due
passiv
interfer
howev
conclud
certainti
current
studi
group
vaccin
piglet
lack
hyopneumoniaespecif
matern
immun
includ
howev
piglet
low
level
matern
hyopneumoniaespecif
ami
time
vaccin
produc
hyopneumoniaespecif
antibodi
follow
vaccin
indic
vaccin
induc
ami
respons
old
pig
depend
upon
level
matern
antigenspecif
ami
agreement
possibl
piglet
respond
hyopneumonia
vaccin
igm
respons
howev
elisa
test
use
lack
isotyp
specif
igg
like
overshadow
igm
respons
sampl
test
includ
group
spf
piglet
may
result
clear
interfer
result
spf
piglet
repres
commerci
pig
hyopneumonia
vaccin
one
commonli
use
vaccin
across
swine
farm
data
report
repres
field
condit
unclear
hyopneumonia
p
ratio
greater
vs
np
piglet
compar
vs
vp
piglet
dpv
differ
may
attribut
interanim
variat
plethora
data
demonstr
passiv
interfer
matern
immun
neonat
ami
respons
follow
vaccin
howev
report
assess
cmi
respons
follow
neonat
vaccin
face
mdi
limit
pauciti
inform
regard
neonat
cmi
respons
vaccin
face
mdi
inform
exist
larg
restrict
vitro
studi
exampl
antigen
specif
prolif
respons
cytokin
product
demonstr
infant
vaccin
measl
viru
neonat
mice
vaccin
measl
viru
lymphocyt
choriomening
viru
follow
vaccin
face
antigenspecif
mdi
notabl
human
mice
expos
mdi
gestat
detect
antigenspecif
reactiv
neonat
may
result
antigen
prime
utero
lack
exposur
mdi
prenat
make
pig
cattl
hors
excel
model
studi
role
colostr
immun
neonat
yet
report
investig
cmi
follow
neonat
vaccin
speci
current
studi
show
piglet
mdi
respond
hyopneumonia
vaccin
antigen
specif
cmi
respons
unlik
previou
studi
show
evid
cmi
stimul
vivo
dth
test
valuabl
measur
cmi
sinc
dth
test
vivo
test
dth
respons
definit
anamnest
respons
agreement
present
studi
bouma
et
al
show
piglet
challeng
pseudorabi
viru
develop
virusspecif
prolif
respons
regardless
matern
pseudorabi
statu
piglet
pseudorabiesspecif
mdi
vaccin
pseudorabi
lower
pseudorabi
viru
antibodi
titer
counterpart
without
pseudorabiesspecif
mdi
similarli
calv
vaccin
bvdv
face
mdi
develop
cmi
respons
show
evid
anamnest
ami
respons
upon
reexposur
antigen
interestingli
calv
vaccin
bvdv
protect
diseas
even
absenc
specif
ami
respons
therefor
neonat
fail
develop
detect
anamnest
ami
respons
follow
vaccin
face
mdi
signifi
inhibit
immun
respons
rather
vaccin
may
induc
cmi
respons
protect
collect
studi
show
neonat
capabl
gener
cmi
respons
face
mdi
passiv
transfer
mdi
may
interfer
neonat
cmi
neonat
vaccin
face
passiv
immun
alway
result
cmi
respons
capac
neonat
mdi
gener
cmi
respons
follow
vaccin
may
depend
age
immun
matur
vaccin
concentr
matern
ami
time
vaccin
may
play
role
neonat
immun
respons
sinc
level
interfer
may
depend
level
matern
ami
neonat
exampl
piglet
vaccin
siv
csf
experi
cmi
stimul
vaccin
face
high
level
antigenspecif
matern
ami
show
evid
cmi
stimul
follow
vaccin
level
matern
antibodi
low
capac
neonat
gener
specif
cmi
respons
face
mdi
may
reliant
administr
method
vaccin
exampl
piglet
mdi
specif
vaccin
pseudorabi
shed
less
viru
vaccin
administ
intranas
compar
intramuscularli
vaccin
type
immunogen
may
also
influenc
neonat
respons
vaccin
dna
vaccin
especi
allur
neonat
vaccin
paradigm
sinc
replic
vivo
pose
risk
infect
dna
vaccin
induc
immun
respons
neonat
administ
face
mdi
other
adjuv
enhanc
cmi
antigen
present
cpg
motif
may
help
neonat
immun
system
overcom
oppos
effect
matern
ami
differ
neonat
respons
vaccin
may
also
due
presenc
function
matern
lymphoid
cell
time
vaccin
variou
studi
shown
transfer
matern
cell
augment
neonat
respons
nonspecif
specif
antigen
current
studi
piglet
vaccin
hyopneumonia
face
hyopneumoniaespecif
mdi
vs
vp
piglet
exhibit
greater
hyopneumonia
specif
cmi
respons
dpv
compar
group
therefor
cmi
prime
anamnest
respons
dpv
depend
upon
piglet
vaccin
transfer
antigenspecif
mdi
capozzo
et
al
show
neonat
mice
vaccin
measl
viru
face
measl
virusspecif
mdi
exhibit
greater
measlesspecif
cmi
respons
product
lymphoprolifer
compar
neonat
mice
vaccin
measl
without
virusspecif
mdi
taken
togeth
studi
suggest
mdi
play
role
vaccineinduc
cmi
respons
detect
neonat
capozzo
et
al
suggest
cmi
respons
observ
mice
vaccin
measl
viru
face
measl
virusspecif
mdi
due
neonat
cell
stimul
endogen
dendrit
cell
engulf
matern
antibodi
bound
measl
antigen
support
idea
propos
capozzo
et
al
neonat
cell
respond
vaccin
antigen
studi
sinc
dth
lesion
prolif
respons
greater
ns
vp
piglet
compar
ns
np
piglet
dpv
reason
conclud
piglet
deriv
cell
contribut
neonat
respons
hyopneumonia
antigen
addit
neonat
cell
respond
vaccin
suggest
cmi
respons
observ
dpv
also
due
function
activ
prolifer
secret
solubl
immun
mediat
eg
cytokin
transfer
antigenspecif
matern
lymphocyt
restimul
via
neonat
vaccin
previous
shown
matern
lymphocyt
prime
vaccin
transfer
function
piglet
show
transfer
matern
cell
may
stimul
via
piglet
dpv
lymphoprolif
dth
respons
vs
vp
piglet
greater
ns
vp
piglet
research
requir
determin
respons
protect
evid
suggest
matern
microchimer
retain
matern
cell
dna
persist
adulthood
howev
unclear
long
matern
cell
function
offspr
term
strateg
vaccin
regimen
take
advantag
endogen
passiv
immun
persist
function
activ
matern
cmi
recipi
warrant
elucid
whether
persist
function
rather
mere
presenc
anergi
matern
cmi
recipi
requir
antigen
stimul
determin
present
studi
show
matern
hyopneumoniaespecif
ami
cmi
transfer
detect
piglet
transfer
matern
hyopneumoniaespecif
cmi
function
work
concert
vaccin
stimul
endogen
hyopneumoniaespecif
cmi
respond
hyopneumonia
piglet
also
demonstr
vaccin
suffici
prime
dayold
piglet
immun
system
piglet
develop
hyopneumoniaespecif
cmi
respons
vaccin
face
mdi
conclus
vaccin
neonat
pig
hyopneumonia
face
antigenspecif
mdi
result
cmi
prime
anamnest
cmi
respons
follow
subsequ
exposur
hyopneumonia
antigen
studi
approv
univers
minnesota
institut
anim
care
use
committe
anim
care
hous
univers
minnesota
institut
anim
care
use
committe
guidelin
time
studi
anim
hous
commerci
facil
prairi
land
pork
nicollet
mn
known
porcin
reproduct
respiratori
syndrom
viru
neg
accord
facil
protocol
replac
gilt
vaccin
hyopneumonia
myco
silenc
intervet
whitehous
station
nj
usa
day
gilt
acclimat
farm
staff
total
acclimat
period
day
randomli
select
piglet
farm
test
hyopneumonia
pcr
follow
nasal
swab
prior
start
present
studi
hyopneumoniaespecif
pcr
test
perform
use
previous
describ
protocol
swab
neg
hyopneumonia
dna
indic
hyopneumonia
circul
farm
anim
chosen
particip
studi
base
breed
date
gilt
first
pariti
sow
statu
equal
number
gilt
first
pariti
sow
known
sow
randomli
stratifi
one
two
group
boost
prime
base
previou
onfarm
vaccin
boost
anim
vaccin
part
studi
refer
vaccin
prime
anim
vaccin
part
studi
refer
nonvaccin
experiment
vaccin
hyopneumonia
pfizer
anim
health
kalamazoo
mi
usa
adjuv
bacterin
label
singl
dose
administr
healthi
swine
one
day
age
older
given
ml
intramuscular
week
prior
anticip
farrow
date
farrow
monitor
piglet
eartag
birth
ensur
piglet
receiv
matern
cmi
ami
crossfost
practic
among
studi
anim
eighti
piglet
n
per
sow
chosen
base
sow
vaccin
statu
twenti
piglet
vaccin
sow
piglet
nonvaccin
sow
select
randomli
immun
vaccin
given
sow
piglet
vaccin
administ
accord
manufactur
guidelin
result
four
treatment
group
piglet
follow
sow
vaccin
piglet
vaccin
vs
vp
sow
vaccin
piglet
nonvaccin
vs
np
sow
nonvaccin
piglet
vaccin
ns
vp
sow
nonvaccin
piglet
nonvaccin
ns
np
blood
collect
sow
occur
week
prepartum
week
postpartum
blood
collect
jugular
vein
edta
tube
bd
franklin
lake
nj
usa
colostrum
collect
sow
within
hr
farrow
teat
scrub
alcohol
wipe
medlin
mundelein
il
usa
glove
worn
minim
sampl
contamin
colostrum
ml
collect
manual
function
teat
blood
collect
piglet
colostrum
ingest
hr
colostrum
ingest
day
age
blood
collect
via
jugular
venipunctur
steril
edta
tube
blood
sampl
time
express
term
day
post
vaccin
dpv
mononuclear
cell
isol
sow
piglet
blood
via
ficol
densiti
centrifug
describ
modif
piglet
blood
dilut
steril
pb
prior
layer
lymphocyt
separ
media
improv
cell
recoveri
yield
mononuclear
cell
isol
colostrum
describ
cell
microscop
enumer
viabil
assess
via
trypan
blue
exclus
viabil
blood
mononuclear
cell
bmc
least
viabil
colostr
mononuclear
cell
cmc
least
dyedilut
method
use
order
evalu
lymphoprolif
respons
hyopneumonia
cell
stain
membran
stain
carboxyfluorescein
diacet
succinimidyl
ester
cfse
ict
bloomington
mn
usa
wash
rpmi
supplement
fb
u
penicillin
g
per
ml
streptomycin
per
ml
stop
reaction
cell
resuspend
rpmi
plate
duplic
cellswel
round
bottom
plate
cmc
bmc
stimul
hyopneumonia
antigen
describ
hyopneumonia
antigen
prepar
describ
hyopneumonia
passag
harvest
continu
flow
centrifug
x
g
resuspend
trissodium
chlorid
buffer
hyopneumonia
inactiv
one
freezethaw
cycl
sonic
disrupt
nonstimul
cona
sigmaaldrich
st
loui
mo
usa
stimul
cultur
serv
neg
posit
control
respect
experiment
neg
posit
control
analyz
anim
follow
incub
cell
transfer
steril
fac
tube
wash
prolifer
analyz
flow
cytometri
use
fac
calib
flow
cytomet
becton
dickinson
immunocytometri
system
san
jose
ca
usa
nonstain
nonstimul
cell
stain
nonstimul
cell
use
establish
baselin
prolifer
assay
event
acquisit
set
event
region
encompass
cfseposit
quadrant
result
analyz
bd
pro
softwar
bd
bioscienc
san
jose
ca
usa
hyopneumoniaespecif
prolifer
data
describ
percent
hyopneumoniaestimul
prolifer
nonstimul
prolifer
dth
test
use
vivo
measur
cmi
respons
dth
assay
hyopneumonia
perform
origin
appli
modif
hyopneumonia
antigen
use
dth
assay
antigen
use
vitro
prolifer
assay
hyopneumonia
antigen
ml
physiolog
salin
inject
intraderm
piglet
per
group
age
second
set
piglet
per
group
age
pha
ml
physiolog
salin
sigma
st
loui
mo
usa
physiolog
salin
ml
use
posit
neg
control
respect
inject
perform
inguin
region
inject
site
clearli
mark
livestock
paint
dth
inject
site
assess
immedi
h
post
inject
dth
lesion
diamet
measur
digit
calip
dth
data
shown
mean
orthogon
diamet
indur
piglet
subject
dth
test
avoid
possibl
dth
antigen
influenc
subsequ
dth
test
result
hyopneumoniaespecif
antibodi
measur
blood
colostrum
sampl
employ
idexx
elisa
kit
idexx
laboratori
westbrook
main
usa
describ
idexx
hyopneumonia
elisa
kit
isotyp
nonspecif
posit
neg
hyopneumonia
serolog
statu
determin
base
optic
densiti
od
sampl
posit
ratio
p
p
sampl
od
neg
control
od
posit
control
od
neg
control
od
sampl
run
duplic
sampl
mean
use
determin
final
p
ratio
p
ratio
classifi
posit
p
ratio
classifi
neg
normal
data
evalu
prior
statist
analysi
approxim
normal
differ
hyopneumoniaespecif
antibodi
p
ratio
sow
sera
vaccin
differ
hyopneumoniaespecif
antibodi
p
ratio
sera
colostrum
vaccin
nonvaccin
sow
differ
hyopneumoniaespecif
prolifer
cmc
isol
vaccin
nonvaccin
sow
analyz
student
ttest
effect
piglet
vaccin
hyopneumoniaespecif
ami
cmi
respons
piglet
hyopneumoniaespecif
antibodi
p
ratio
hyopneumoniaespecif
prolifer
hyopneumoniaespecif
dth
lesion
size
analyz
via
twoway
anova
piglet
vaccin
sow
vaccin
two
factor
comparison
found
signific
anova
p
analyz
tukey
hsd
method
student
ttest
use
analyz
differ
mean
hyopneumoniaespecif
dth
lesion
orthogon
diamet
differ
hyopneumoniaespecif
antibodi
p
ratio
dpv
dpv
among
piglet
group
statist
analysi
perform
use
graphpad
prism
graph
pad
softwar
inc
ca
usa
ami
antibodymedi
immun
bmc
blood
mononuclear
cell
bvdv
bovin
viral
diarrheal
viru
cmi
cell
mediat
immun
cona
concanavalin
csf
classic
swine
fever
dpv
day
post
vaccin
dth
delay
type
hypersensit
hyopneumonia
mycoplasma
hyopneumonia
mdi
matern
deriv
immun
porcin
circoviru
type
pha
phytohemagglutinin
p
sampl
posit
siv
swine
influenza
viru
tge
transmiss
gastroenter
viru
cmc
colostr
mononuclear
cell
ns
vp
nonvaccin
sow
vaccin
piglet
vs
vp
vaccin
sow
vaccin
piglet
vs
np
vaccin
sow
nonvaccin
piglet
ns
np
nonvaccin
sow
nonvaccin
piglet
none
author
paper
financi
person
relationship
peopl
organ
could
inappropri
influenc
bia
content
paper
mb
conceiv
studi
particip
design
sampl
collect
immunoassay
data
analysi
draft
manuscript
kt
particip
studi
design
sampl
collect
coordin
farm
site
carri
immunoassay
twm
particip
studi
design
coordin
help
draft
manuscript
author
read
approv
final
manuscript
